Global and United States Transfection Reagent and Equipment Market Report & Forecast 2022-2028

Transfection technology is recognized as an integral part of research programs pertaining to thorough investigation of various chromosomal anomalies. Hence, rising cancer prevalence of cancer as well as genetic conditions is anticipated to provide a fillip to the market. Furthermore, funds and grants by funding and government bodies are likely to back the growth of the market.
Market Analysis and Insights: Global and United States Transfection Reagent and Equipment Market
This report focuses on global and United States Transfection Reagent and Equipment market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Transfection Reagent and Equipment market size is estimated to be worth US$ 776.9 million in 2022 and is forecast to a readjusted size of US$ 994.4 million by 2028 with a CAGR of 4.2% during the review period. Fully considering the economic change by this health crisis, by Type, Transfection Reagent accounting for % of the Transfection Reagent and Equipment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Gene Expression was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
Funding and federal agencies, such as National Science Foundation (NSF), are offering the biotechnology sector with huge funding to carry out their biotechnology-based investigational studies. Moreover, international funding bodies such as NIH and Welcome Trust are projected to play a crucial role in the growth of the market by providing funds for genetic research studies. Such significant funds and grants are poised to boost the adoption of transfection technology over the forecast period.
Global Transfection Reagent and Equipment Scope and Market Size
Transfection Reagent and Equipment market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Transfection Reagent and Equipment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Transfection Reagent and Equipment market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Transfection Reagent
Transfection Equipment
Segment by Application
Gene Expression
Protein Production
Cancer Research
Therapeutics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Thermo Fisher Scientific
Promega
Lonza
Qiagen
Mirus Bio
EMD Millipore
Bio-Rad Laboratories
OriGene Technologies
Merck KgaA